InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Puromycin | Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol... | 2022 | Cell Rep. | Gros M. et al. | DOI: 10.1016/j.celrep.2022.111205 |
| OVA peptides | Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol... | 2022 | Cell Rep. | Gros M. et al. | DOI: 10.1016/j.celrep.2022.111205 |
| ODN 2395 - TLR9 ligand | Endocytic membrane repair by ESCRT-III controls antigen export to the cytosol... | 2022 | Cell Rep. | Gros M. et al. | DOI: 10.1016/j.celrep.2022.111205 |
| HEK-Blue™ Detection | Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm form... | 2022 | PLoS Pathog. | Nicastro L.K. et al. | DOI: 10.1371/journal.ppat.1010742 |
| ODN 1668 - TLR9 ligand | Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm form... | 2022 | PLoS Pathog. | Nicastro L.K. et al. | DOI: 10.1371/journal.ppat.1010742 |
| Mouse TLR2 Reporter HEK293 Cells (NF-κB) | Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm form... | 2022 | PLoS Pathog. | Nicastro L.K. et al. | DOI: 10.1371/journal.ppat.1010742 |
| Pam3CSK4 | Assembly of ordered DNA-curli fibril complexes during Salmonella biofilm form... | 2022 | PLoS Pathog. | Nicastro L.K. et al. | DOI: 10.1371/journal.ppat.1010742 |
| Gardiquimod™ | Immunomodulatory effects of D-allose on cytokine production by plasmacytoid d... | 2022 | BBRC | Takao K. et al. | DOI: 10.1016/j.bbrc.2022.08.037 |
| Loxoribine | Immunomodulatory effects of D-allose on cytokine production by plasmacytoid d... | 2022 | BBRC | Takao K. et al. | DOI: 10.1016/j.bbrc.2022.08.037 |
| diABZI (compound 3) | The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. | 2022 | Cell Rep. | Pereira M. et al. | DOI: 10.1016/j.celrep.2022.111225 |
| LPS-EB (LPS from E. coli O111:B4) | The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. | 2022 | Cell Rep. | Pereira M. et al. | DOI: 10.1016/j.celrep.2022.111225 |
| Pam3CSK4 | The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. | 2022 | Cell Rep. | Pereira M. et al. | DOI: 10.1016/j.celrep.2022.111225 |
| R848 (Resiquimod) | The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. | 2022 | Cell Rep. | Pereira M. et al. | DOI: 10.1016/j.celrep.2022.111225 |
| Poly(I:C) HMW | The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways. | 2022 | Cell Rep. | Pereira M. et al. | DOI: 10.1016/j.celrep.2022.111225 |
| Puromycin | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| Hygromycin B Gold | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| G418 (Geneticin) | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| Zeocin® | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| Human ACE2 & TMPRSS2 expressing HEK293 Cells | Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutra... | 2022 | Med (N Y) | Duty J.A. et al. | DOI: 10.1016/j.medj.2022.08.002 |
| pCpGfree-promoter | Identification of TMEM129, encoding a ubiquitin-protein ligase, as an effecto... | 2022 | Arthritis Res Ther. | Brumwell A. et al. | DOI: 10.1186/s13075-022-02882-y |